In the bloodstream, cholesterol travels in particles called lipoproteins. Low-Density Lipoprotein (LDL) delivers cholesterol ...

It is one of the most prescribed drugs in the world, with more than 200 million people taking the medication globally. But ...

Leading RNA drug developer Suzhou Ribo Life Science Co. Ltd. passed its hearing for a listing on the Hong Kong Stock Exchange, marking the official launch of its IPO, according to its post-hearing ...

SaveHealth reports on popular statin medications that lower cholesterol and cardiovascular risks, highlighting their benefits ...

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

Northwestern University scientists are developing an experimental drug that could serve as an early intervention for Alzheimer’s disease.

A third-generation PCSK9 inhibitor, lerodalcibep is indicated as an adjunct to diet and exercise to reduce LDL cholesterol in ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

The FDA has approved lerodalcibep-liga, a third-generation injectable PCSK9 inhibitor, to reduce LDL cholesterol in adults ...

The FDA recalled about 11,100 bottles of Ziac after finding trace contamination with ezetimibe. The recall includes 30-, 100-, and 500-count bottles with lot with expiration dates ranging from ...

The U.S. Food and Drug Administration (FDA) issued a nationwide recall of thousands of bottles of blood-pressure medication last week after discovering cross-contamination with another drug. Federal ...